Fintel reports that on November 5, 2024, JMP Securities downgraded their outlook for Sana Biotechnology (NasdaqGS:SANA) from ...

In a report released today, Alec Stranahan from Bank of America Securities maintained a Buy rating on Sana Biotechnology (SANA – Research ...

On Tuesday, Sana Biotechnology Inc (SANA) stock saw a decline, ending the day at $3.39 which represents a decrease of $-0.37 or -9.84% from the prior close of $3.76. The stock opened at $3.5 and ...

About a year after cutting staff by 29%, Sana Biotechnology will trim its workforce as it increases investment in its type 1 ...

JMP Securities downgraded Sana Biotechnology (SANA) to Market Perform from Outperform without a price target after the company announced a ...

Just three years removed from a lucrative IPO, the company will cut jobs for a third time and invest more heavily in cell ...

Sana Biotechnology has become the latest cell therapy biotech to shift resources from cancer to autoimmune diseases as part of a ...

JMP has downgraded Sana Biotechnology (NASDAQ:SANA) to market perform from market outperform, citing uncertainty surrounding ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session Tesla, Spirit Airlines, New York Community Bancorp And Other Big Stocks Moving Lower On Monday U.S ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Short interest in Sana Biotechnology Inc (NASDAQ:SANA) decreased during the last reporting period, falling from 31.81M to 31.17M. This put 29.07% of the company's publicly available shares short.